CTCBIO Inc (060590) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.079x

Based on the latest financial reports, CTCBIO Inc (060590) has a cash flow conversion efficiency ratio of 0.079x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.64 Billion ≈ $3.82 Million USD) by net assets (₩71.75 Billion ≈ $48.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of CTCBIO Inc to measure how much of total assets are equity-financed.

CTCBIO Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how CTCBIO Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CTCBIO Inc (060590) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

CTCBIO Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CTCBIO Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Batm Advanced Communications Ltd TA:BVC	-0.054x
Century Synthetic Fiber Corp VN:STK	-0.041x
Romerike Sparebank OL:ROMER	-0.198x
Nirvana Daii Public Company Limited BK:NVD	0.045x
Done.ai Group AB ST:TINGS-B	0.009x
OptimumBank Holdings, Inc. NASDAQ:OPHC	0.016x
BeyondSpring Inc NASDAQ:BYSI	0.236x
Joinsoon Electronics MFG Co Ltd TWO:3322	-0.067x

Annual Cash Flow Conversion Efficiency for CTCBIO Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of CTCBIO Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see 060590 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩69.62 Billion ≈ $47.18 Million	₩4.50 Billion ≈ $3.05 Million	0.065x	-40.69%
2023-12-31	₩75.44 Billion ≈ $51.13 Million	₩8.22 Billion ≈ $5.57 Million	0.109x	-42.66%
2022-12-31	₩95.96 Billion ≈ $65.03 Million	₩18.22 Billion ≈ $12.35 Million	0.190x	+150.02%
2021-12-31	₩85.01 Billion ≈ $57.61 Million	₩6.46 Billion ≈ $4.38 Million	0.076x	+1036.38%
2020-12-31	₩76.32 Billion ≈ $51.72 Million	₩510.09 Million ≈ $345.68K	0.007x	-70.18%
2019-12-31	₩74.74 Billion ≈ $50.65 Million	₩1.68 Billion ≈ $1.14 Million	0.022x	+178.74%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩-2.47 Billion ≈ $-1.68 Million	-0.028x	-813.17%
2017-12-31	₩73.98 Billion ≈ $50.14 Million	₩295.30 Million ≈ $200.12K	0.004x	-94.71%
2016-12-31	₩90.89 Billion ≈ $61.60 Million	₩6.86 Billion ≈ $4.65 Million	0.076x	+420.86%
2015-12-31	₩99.14 Billion ≈ $67.19 Million	₩1.44 Billion ≈ $974.04K	0.014x	+456.42%
2014-12-31	₩85.49 Billion ≈ $57.94 Million	₩-347.74 Million ≈ $-235.66K	-0.004x	-113.69%
2013-12-31	₩92.23 Billion ≈ $62.50 Million	₩2.74 Billion ≈ $1.86 Million	0.030x	--

About CTCBIO Inc

KQ:060590 Korea Biotechnology

Market Cap

$47.31 Million

₩69.81 Billion KRW

Market Cap Rank

#22040 Global

#1326 in Korea

Share Price

₩2920.00

Change (1 day)

+5.80%

52-Week Range

₩2700.00 - ₩7450.00

All Time High

₩18000.00